Vaxneuvance™ Pneumonia Vaccine Indicated for People 6 Weeks of Age and Older Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2 mcg - 4 mcg - 30 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL

Name: Vaxneuvance™ Pneumonia Vaccine Indicated for People 6 Weeks of Age and Older Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2 mcg - 4 mcg - 30 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
Brand: Merck
SKU: USAMP#10536404
Price: 3056 USD
Availability: InStock

USAMP#10536404SKU: 00006432903Vaxneuvance™

License Required

Product Spotlight

VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
10 Per Package

Product Spotlight

VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
10 Per Package